The metabolism of the storage polysaccharide glycogen is intimately linked with insulin action and blood glucose homeostasis. Insulin activates both glucose transport and glycogen synthase in skeletal muscle. The central issue of a long-standing debate is which of these two effects determines the rate of glycogen synthesis in response to insulin. Recent studies with transgenic animals indicate that, under appropriate conditions, each process can contribute to determining the extent of glycogen accumulation. Insulin causes stable activation of glycogen synthase by promoting dephosphorylation of multiple sites in the enzyme. A model linking this action to the mitogen-activated protein kinase signaling pathway via the phosphorylation of the regulatory subunit of glycogen synthase phosphatase gained widespread acceptance. However, the most recent evidence argues strongly against this mechanism. A newer model, in which insulin inactivates the enzyme glycogen synthase kinase-3 via the protein kinase B pathway, has emerged. Though promising, this model still does not completely explain the molecular basis for the insulin-mediated activation of glycogen synthase, which remains one of the many unknowns of insulin action.
Skip Nav Destination
Article navigation
Perspectives in Diabetes|
April 01 1997
New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin
John C Lawrence, Jr;
John C Lawrence, Jr
Departments of Pharmacology and Medicine (J.C.L.), University of Virginia School of Medicine
Charlottesville, Virginia
Search for other works by this author on:
Peter J Roach
Peter J Roach
Department of Biochemistry and Molecular Biology (P.J.R.), Indiana University School of Medicine
Indianapolis, Indiana
Search for other works by this author on:
Address correspondence and reprint requests to Dr. John C. Lawrence, Jr., Department of Pharmacology, University of Virginia School of Medicine, Jordan Building, 1300 Jefferson Park Ave., Charlottesville, VA 22908. jcl3p@avery.med.virginia.edu.
1
cdk, cyclin-dependent kinase; EGF, epidermal growth factor; GSK-3, glycogen synthase kinase-3; ISPK, insulin-stimulated protein kinase; JNK, Jun NH2-terminal kinase; MAP kinase, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; PKB, protein kinase B; RSK, ribosomal protein S6 kinase.
Diabetes 1997;46(4):541–547
Article history
Received:
October 30 1996
Revision Received:
January 29 1997
Accepted:
January 29 1997
PubMed:
9075792
Citation
John C Lawrence, Peter J Roach; New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin. Diabetes 1 April 1997; 46 (4): 541–547. https://doi.org/10.2337/diab.46.4.541
Download citation file:
349
Views